These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 2592943)
1. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer. Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943 [TBL] [Abstract][Full Text] [Related]
2. [Determination of the SCC antigen in the serum of patients with cervical cancer]. Crombach G; Würz H; Bolte A Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046 [TBL] [Abstract][Full Text] [Related]
3. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers]. Geyer H; Schwörer D; Pfleiderer A Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888 [TBL] [Abstract][Full Text] [Related]
4. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)]. Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers. Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391 [TBL] [Abstract][Full Text] [Related]
6. Clinical value of squamous cell carcinoma antigen (SCC-A) in Egyptian gynecologic cancer patients. Salman T; el-Ahmady O; Tony O; Darwish M Anticancer Res; 1997; 17(4B):3083-6. PubMed ID: 9329607 [TBL] [Abstract][Full Text] [Related]
7. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay. Holloway RW; To A; Moradi M; Boots L; Watson N; Shingleton HM Obstet Gynecol; 1989 Dec; 74(6):944-9. PubMed ID: 2586961 [TBL] [Abstract][Full Text] [Related]
8. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix]. Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050 [TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix. Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279 [TBL] [Abstract][Full Text] [Related]
10. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449 [TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma antigen in patients with cancer of the uterine cervix. Fuith LC; Daxenbichler G Gynecol Obstet Invest; 1988; 26(1):77-82. PubMed ID: 3169633 [TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma]. Luan XM; Zhang Y; Wang SZ; Wang N; Li W; Zhang Q; Wei H; Zhang SL Zhonghua Yi Xue Za Zhi; 2012 May; 92(19):1330-3. PubMed ID: 22883121 [TBL] [Abstract][Full Text] [Related]
13. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer. Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720 [TBL] [Abstract][Full Text] [Related]
14. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix]. Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611 [TBL] [Abstract][Full Text] [Related]
15. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence. Rose PG; Baker S; Fournier L; Nelson BE; Hunter RE Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907 [TBL] [Abstract][Full Text] [Related]
16. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225 [TBL] [Abstract][Full Text] [Related]
17. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC). Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591 [TBL] [Abstract][Full Text] [Related]
18. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117 [TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer. Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G J Clin Oncol; 1994 Nov; 12(11):2309-16. PubMed ID: 7964945 [TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas]. Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]